BioXcel Therapeutics (BTAI) is banking on artificial intelligence to gain a second speedy Food and Drug Administration approval. The possibility could drive BTAI stock higher. The neuroscience industry is riddled with failures. Even in surer areas of drug development, it can take a decade or longer to bring a new medicine to market. But BioXcel did […]

Kyowa Kirin now leads the commercial efforts for Crysvita in 40 countries, continuing its commitment to address the needs of people living with rare diseases. Kyowa Kirin, Inc., a leading global specialty pharmaceutical company, has assumed primary commercial leadership for Crysvita (burosumab injection) in the United States and Canada from Ultragenyx Pharmaceutical, Inc., as per […]

BOSTON — Gold nanoparticles in an oral suspension helped patients with relapsing multiple sclerosis (MS) preserve ocular and overall function when added to standard medications in a phase II trial, a researcher said here. Those assigned to the product, dubbed CNM-Au8, saw an improvement in low-contrast letter acuity (LCLA) of 3.13 letters relative to a […]